145 related articles for article (PubMed ID: 25473892)
21. Bag3 promotes resistance to apoptosis through Bcl-2 family members in non-small cell lung cancer.
Zhang Y; Wang JH; Lu Q; Wang YJ
Oncol Rep; 2012 Jan; 27(1):109-13. PubMed ID: 21971866
[TBL] [Abstract][Full Text] [Related]
22. Differences in the mechanisms of proapoptotic BH3 proteins binding to Bcl-XL and Bcl-2 quantified in live MCF-7 cells.
Aranovich A; Liu Q; Collins T; Geng F; Dixit S; Leber B; Andrews DW
Mol Cell; 2012 Mar; 45(6):754-63. PubMed ID: 22464442
[TBL] [Abstract][Full Text] [Related]
23. Underexpression of transcriptional regulators is common in metastatic breast cancer cells overexpressing Bcl-xL.
Méndez O; Martín B; Sanz R; Aragüés R; Moreno V; Oliva B; Stresing V; Sierra A
Carcinogenesis; 2006 Jun; 27(6):1169-79. PubMed ID: 16492678
[TBL] [Abstract][Full Text] [Related]
24. 53BP1 suppresses epithelial-mesenchymal transition by downregulating ZEB1 through microRNA-200b/429 in breast cancer.
Kong X; Ding X; Li X; Gao S; Yang Q
Cancer Sci; 2015 Aug; 106(8):982-9. PubMed ID: 26011542
[TBL] [Abstract][Full Text] [Related]
25. Bcl-XL is qualitatively different from and ten times more effective than Bcl-2 when expressed in a breast cancer cell line.
Fiebig AA; Zhu W; Hollerbach C; Leber B; Andrews DW
BMC Cancer; 2006 Aug; 6():213. PubMed ID: 16928273
[TBL] [Abstract][Full Text] [Related]
26. [The effects of antisense oligonucleotides bcl-2/bcl-xl and bcl-2 on proliferation and apoptosis of breast cancer cells].
Ma C; Xie JW; Kuang AR; Huang R; Tang GS
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Sep; 40(5):780-3. PubMed ID: 19950582
[TBL] [Abstract][Full Text] [Related]
27. Bcl-xL inhibition by molecular-targeting drugs sensitizes human pancreatic cancer cells to TRAIL.
Hari Y; Harashima N; Tajima Y; Harada M
Oncotarget; 2015 Dec; 6(39):41902-15. PubMed ID: 26506422
[TBL] [Abstract][Full Text] [Related]
28. Bcl-XL antisense oligonucleotides coupled with antennapedia enhances radiation-induced apoptosis in pancreatic cancer.
Masui T; Hosotani R; Ito D; Kami K; Koizumi M; Mori T; Toyoda E; Nakajima S; Miyamoto Y; Fujimoto K; Doi R
Surgery; 2006 Aug; 140(2):149-60. PubMed ID: 16904964
[TBL] [Abstract][Full Text] [Related]
29. [Bcl-XL antisense oligodeoxynucleotide sensitizes human esophageal cancer cell line to 5-fluorouracil].
Zhang L; Wen HT; Wang LX; Zhang L; Zhang YH
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):173-7. PubMed ID: 16875599
[TBL] [Abstract][Full Text] [Related]
30. Reversal of Mutant KRAS-Mediated Apoptosis Resistance by Concurrent Noxa/Bik Induction and Bcl-2/Bcl-xL Antagonism in Colon Cancer Cells.
Okamoto K; Zaanan A; Kawakami H; Huang S; Sinicrope FA
Mol Cancer Res; 2015 Apr; 13(4):659-69. PubMed ID: 25548100
[TBL] [Abstract][Full Text] [Related]
31. Adipocytes can induce epithelial-mesenchymal transition in breast cancer cells.
Lee Y; Jung WH; Koo JS
Breast Cancer Res Treat; 2015 Sep; 153(2):323-35. PubMed ID: 26285644
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of Bcl-xL in human breast cancer cells enhances organ-selective lymph node metastasis.
España L; Fernández Y; Rubio N; Torregrosa A; Blanco J; Sierra A
Breast Cancer Res Treat; 2004 Sep; 87(1):33-44. PubMed ID: 15377849
[TBL] [Abstract][Full Text] [Related]
33. Systemic delivery of siRNA specific to tumor mediated by atelocollagen: combined therapy using siRNA targeting Bcl-xL and cisplatin against prostate cancer.
Mu P; Nagahara S; Makita N; Tarumi Y; Kadomatsu K; Takei Y
Int J Cancer; 2009 Dec; 125(12):2978-90. PubMed ID: 19422046
[TBL] [Abstract][Full Text] [Related]
34. Epithelial to mesenchymal transition in an epidermal growth factor receptor-mutant lung cancer cell line with acquired resistance to erlotinib.
Suda K; Tomizawa K; Fujii M; Murakami H; Osada H; Maehara Y; Yatabe Y; Sekido Y; Mitsudomi T
J Thorac Oncol; 2011 Jul; 6(7):1152-61. PubMed ID: 21597390
[TBL] [Abstract][Full Text] [Related]
35. Bcl-xL is overexpressed in hormone-resistant prostate cancer and promotes survival of LNCaP cells via interaction with proapoptotic Bak.
Castilla C; Congregado B; Chinchón D; Torrubia FJ; Japón MA; Sáez C
Endocrinology; 2006 Oct; 147(10):4960-7. PubMed ID: 16794010
[TBL] [Abstract][Full Text] [Related]
36. [Inhibitory effects of transfected Bcl-XL antisense oligodeoxynucleotide on proliferation of esophageal cancer cells and growth of human esophageal carcinoma in nude mice].
Zhang L; Wen HT; Zhang L; Chen KS; Zhang YH
Zhonghua Bing Li Xue Za Zhi; 2005 Jul; 34(7):402-6. PubMed ID: 16251044
[TBL] [Abstract][Full Text] [Related]
37. Downregulation of the expression of B‑cell lymphoma-extra large by RNA interference induces apoptosis and enhances the radiosensitivity of non‑small cell lung cancer cells.
Yang C; Huang W; Yan L; Wang Y; Wang W; Liu D; Zuo X
Mol Med Rep; 2015 Jul; 12(1):449-55. PubMed ID: 25683634
[TBL] [Abstract][Full Text] [Related]
38. Breast cancer-associated fibroblasts induce epithelial-to-mesenchymal transition in breast cancer cells.
Soon PS; Kim E; Pon CK; Gill AJ; Moore K; Spillane AJ; Benn DE; Baxter RC
Endocr Relat Cancer; 2013 Feb; 20(1):1-12. PubMed ID: 23111755
[TBL] [Abstract][Full Text] [Related]
39. Epithelial to mesenchymal transition is associated with rapamycin resistance.
Holder AM; Akcakanat A; Adkins F; Evans K; Chen H; Wei C; Milton DR; Li Y; Do KA; Janku F; Meric-Bernstam F
Oncotarget; 2015 Aug; 6(23):19500-13. PubMed ID: 25944619
[TBL] [Abstract][Full Text] [Related]
40. An IL6-STAT3 loop mediates resistance to PI3K inhibitors by inducing epithelial-mesenchymal transition and cancer stem cell expansion in human breast cancer cells.
Yang L; Han S; Sun Y
Biochem Biophys Res Commun; 2014 Oct; 453(3):582-7. PubMed ID: 25285632
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
